Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-329804

EVP, Chief Development Officer gave up 6,674 shares (to pay taxes)

  • EVP, Chief Development Officer acquired 23,463 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Forbes William P · EVP, Chief Development Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-30 Exercise or conversion : show line 1 in the form +11,769 236,153 D
2026-07-30 Shares withheld for taxes : show line 2 in the form −3,348 $0.50 $1,674 232,805 D
2026-07-31 Exercise or conversion : show line 3 in the form +11,694 244,499 D
2026-07-31 Shares withheld for taxes : show line 4 in the form −3,326 $0.50 $1,663 241,173 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-07-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −11,769 164,776 D
2026-07-31 Exercise or conversion : show line 6 in the form Restricted Stock Units −11,694 116,944 D
Loading xslF345X06/ownership.xml…